Cargando…

Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines

Hyperlipidemia is an important risk factor for ischemic stroke; the Stroke Prevention by Aggressive Reduction in Cholesterol Level and Treat Stroke to Target studies have shown that statins are beneficial for patients with stroke and that a low target for low-density lipoprotein cholesterol (LDL-C)...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kim, Jong S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189863/ https://www.ncbi.nlm.nih.gov/pubmed/34102752 http://dx.doi.org/10.5853/jos.2021.01249

Ejemplares similares

LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)

Synergistic effects of elevated homocysteine level and abnormal blood lipids on the onset of stroke
por: Hao, Lu, et al.
Publicado: (2013)

The Impact of the Blood Lipids Levels on Arterial Stiffness
por: Baba, Mirela, et al.
Publicado: (2023)

Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
por: Qin, Hao, et al.
Publicado: (2023)

‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’
por: Borghi, Claudio, et al.
Publicado: (2022)

ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses
por: Yang, Qian, et al.
Publicado: (2018)

Levels of Lipid Parameters in Children with Arterial Ischemic Stroke and Headache: Case-Control Study and Meta-Analysis
por: Sarecka-Hujar, Beata, et al.
Publicado: (2021)

The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021)

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
por: Temporelli, Pier Luigi, et al.
Publicado: (2021)

Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke
por: Sandhu, Alexander T., et al.
Publicado: (2022)

Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
por: Mueller, Linda, et al.
Publicado: (2022)

Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy
por: Zhang, Qing-Hui, et al.
Publicado: (2018)

The Long-Term Effects of Pitavastatin on Blood Lipids and Platelet Activation Markers in Stroke Patients: Impact of the Homocysteine Level
por: Sugimoto, Hideki, et al.
Publicado: (2014)

Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial
por: Bath, Philip M., et al.
Publicado: (2017)

Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
por: Gynnild, Mari Nordbø, et al.
Publicado: (2022)

DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke
por: Li, Wei-Jun, et al.
Publicado: (2018)

Role of Lipid-Lowering Therapy in Peripheral Artery Disease
por: Belur, Agastya D., et al.
Publicado: (2022)

The Relationship of Large-Artery Atherothrombotic Stroke with Plasma Trimethylamine N-Oxide Level and Blood Lipid-Related Indices: A Cross-Sectional Comparative Study
por: Xu, Dongjuan, et al.
Publicado: (2021)

Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage
por: Ma, Yingxu, et al.
Publicado: (2016)

Reconsidering Patient Participation in Guideline Development
por: van de Bovenkamp, Hester M., et al.
Publicado: (2008)

Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
por: O’Neil, Adam, et al.
Publicado: (2022)

Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice
por: Hoek-van den Hil, Elise F., et al.
Publicado: (2013)

Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke
por: Kloska, Anna, et al.
Publicado: (2020)

Association between the XKR6 rs7819412 SNP and serum lipid levels and the risk of coronary artery disease and ischemic stroke
por: Zheng, Peng-Fei, et al.
Publicado: (2019)

Systematic evaluation of high-level visual deficits and lesions in posterior cerebral artery stroke
por: Robotham, Ro Julia, et al.
Publicado: (2023)

Effect of Intensive and Standard Lipid-Lowering Therapy on the Progression of Stroke in Patients With Coronary Artery Syndromes: A Meta-Analysis of Randomized Controlled Trials
por: Xie, Chengjuan, et al.
Publicado: (2020)

Utilization and adherence to guideline-recommended lipid-lowering therapy at an academic medical center
por: Alburikan, Khalid A., et al.
Publicado: (2017)

The influence of MRAS gene variants on ischemic stroke and serum lipid levels in Chinese Han population
por: Song, Yan, et al.
Publicado: (2019)

Association of Non-LDL Indices with Recurrent Stroke Risk while on Lipid-Modifying Therapy
por: Park, Jong-Ho, et al.
Publicado: (2020)

Effect of blood lipids and lipid-lowering therapies on osteoarthritis risk: A Mendelian randomization study
por: Wang, Zhaolun, et al.
Publicado: (2022)

Acute-Phase Stroke Outcome and Lipids
por: Serhat Tokgoz, Osman, et al.
Publicado: (2021)

Correction: Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice
por: Hoek-van den Hil, Elise F., et al.
Publicado: (2013)

Efficiency Assessment of Bacterial Cellulose on Lowering Lipid Levels In Vitro and Improving Lipid Metabolism In Vivo
por: Zhang, Wen, et al.
Publicado: (2022)

Erythematous reactions to two ultraviolet excimer therapy devices with different irradiance levels: Reconsidering the reciprocity law
por: Togawa, Yaei, et al.
Publicado: (2023)

Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids
por: Blackburn, Daniel J, et al.
Publicado: (2013)

Recent advances in preventing cardiovascular disorders by managing lipid levels
por: Olsson, Anders G
Publicado: (2010)

The Future of Lipid-Lowering Therapy
por: van Zwol, Willemien, et al.
Publicado: (2019)

Cerebral blood flow and cognitive outcome after pediatric stroke in the middle cerebral artery
por: Steiner, Leonie, et al.
Publicado: (2021)

Lipid Paradox in Statin-Naïve Acute Ischemic Stroke But Not Hemorrhagic Stroke
por: Cheng, Kai-Hung, et al.
Publicado: (2018)

Effect of lipid lowering tablet on blood lipid in hyperlipidemia model rats
por: Kong, Xuejun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6ski285apfadamvlrrm5q74n5u